Background: Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Since the American Thyroid Association's …

Thyroid cancer is the most common endocrine cancer. The discovery of new biomarkers for
thyroid cancer has significantly improved the understanding of the molecular pathogenesis …

Abstract Mutations 1 295 228 C> T and 1 295 250 C> T (termed C228T and C250T
respectively), corresponding to− 124 C> T and− 146 C> T from the translation start site in the …

In recent years, the T1799A B-type Raf kinase (BRAF) mutation in thyroid cancer has
received enthusiastic investigation, and significant progress has been made toward …

The past two decades have seen numerous developments in the understanding of the
origins and biology of papillary thyroid carcinoma. Advances in molecular biology …

Context: Individualized management, incorporating papillary thyroid cancer (PTC) variant-
specific risk, is conceivably a useful treatment strategy for PTC, which awaits comprehensive …

Papillary thyroid carcinomas are the most common endocrine cancer and are usually
associated with good survival. However, some variants of papillary thyroid carcinomas may …

Background The diffuse sclerosing (DSV) and tall cell (TCV) variants are considered
aggressive subtypes of papillary thyroid cancer (PTC) for which data are limited. Methods …

Importance While well-differentiated papillary thyroid carcinoma (WDPTC) outcomes have
been well characterized, the prognostic implications of more aggressive variants are far less …

BACKGROUND. Radioactive iodine‐refractory (RAIR) 18F‐fluorodeoxyglucose (FDG)‐
positron emission tomography (PET) positive thyroid carcinomas represent the major cause …